Media and Events

 Dr Minh-Thu Cao Xuan will proudly represent team Opyl as part of the Global Victoria supported Australian delegation. During this exciting week, Minh-Thu will engage in high-level meetings and networking events with leading CROs and pharmaceutical companies. She will also attend BIO-Europe Spring 2025, taking place from March 17–19 in Milan, Italy. BIO-Europe Spring is the premier partnering conference for the life sciences industry, bringing together over 3,700 delegates from 2,000 companies across...

Dr Minh-Thu Cao Xuan, represented Opyl at the 43rd J.P. Morgan Healthcare Conference in January to spotlight TrialKey— the global leader in clinical trial optimisation, combining AI-driven biostatistical validation, computational simulations, explainable AI, and robust predictive modelling. This premier event is hosted by J.P. Morgan and draws global leaders, investors, and innovators in healthcare, making it the perfect forum to showcase the value of Australian biotech innovation on the world stage. The...

PDC Inaugural Event: Accelerating Drug Market Entry through AI-Driven Validation At the inaugral Pharmaceutical Development Conference in October 2024, Opyl’s Executive Chairman Saurabh Jain delivered an insightful presentation, asking, “What if you could accelerate drug market entry by optimising trial designs through AI-driven biostatistical validation?” The event had over 20+ scientific presentations, case studies, and professional networking opportunities, covering key topics like...

VHW Keynote: Increasing Clinical Trial Efficiency with AI Dr Minh-Thu Cao Xuan was the keynote speaker on the Digital Healthcare stage where she presented ‘IncreasingClinical Trial Efficiency with AI’. Dr Cao Xuan showcased the several use cases of TrialKey’s software as well as sharing some case studies of TrialKey optimised trial designs.

Bio HK: Showcasing AI Innovation in Clinical Trial Design In August 2024, Dr Minh-Thu Cao Xuan was a speaker at the Bio Hong Kong Pitching sessions, where she showcased the exceptional innovation that our platform brings to the biotechnology sector. TrialKey’s AI-driven capabilities for optimising clinical trial designs stood out for its ability to transform trial outcomes through advanced data analytics and biostatistical validation.

ShareCafe Webinar: Exploring AI-Powered Biostatistical Validation in Clinical Trials Executive Chairman, Saurabh Jain presented at the ShareCafe ‘Hidden Gems’ webinar on 27 September 2024 where he discussed how Opyl’s AI-driven platform, TrialKey, global leader in biostatistical validation, optimises and predicts trial completion for clinical trials for our clients and partners.

Bio Taiwan: Showcasing Australian Biotech Innovation in AI-Driven Clinical Solutions TrialKey joined 20 other incredible Australian biotech companies, for Australia’s largest national pavilion at BIO Asia–Taiwan in July 2024.Bernice Averion, our Head of Marketing and Communications, and Minh-Thu Cao Xuan, our Business Development Manager, showcased TrialKey’s AI-driven solutions, including our database of clinical trial insights and our TrialGen Clinical Trial Design Simulator.

Bioconnections Panel: Scaling AI in Clinical Trial Development In July 2024, CTO, Damon Rasheed, joined a panel to discuss “Achieving Scale in World’s Best Practice in Development in the Next 5-10 Years: What Would This Take?”, alongside esteemed colleagues including Dr. Amanda Caples, Dr. Felicia Pradera, Dr Amanda Buttery GAICD, and Dr. Anand Gautam, highlighting the importance of strategic investments in AI and data analytics. Our Executive Chairman, Saurabh Jain, delivered an...

ARCS Australia: Future-Proofing Medicine with AI During June 2024, Executive Chairman, Saurabh Jain presented at ARCS Australia Annual Conference in Sydney on the topic “Future-Proofing Medicine: AI’s Role in Predicting Clinical Trial Success.” This session, part of the session on “Revolutionising Pharmaceutical Regulatory Efficiency: Harnessing the Power of AI and Large Language Models (LLM),” was moderated by Carl Bufe, Director of PharmOut, and featured fellow speaker...

GCTC London: The Trial Before the Trial – Shaping the Future of Medical Research During May 2024, TrialKey presented at the 7th Annual Global Clinical Trials Connect in London. Executive Chairman, Saurabh Jain, and CTO Damon Rasheed presented “The Trial Before the Trial: How TrialKey.ai is Shaping the Future of Medical Research” illustrating how our AI technology is revolutionising clinical trial design and improving success rates.